Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Max Plischke"'
Autor:
Markus Riegersperger, Max Plischke, Anita Jallitsch-Halper, Corinna Steinhauser, Manuela Födinger, Wolfgang C Winkelmayer, Daniela Dunkler, Gere Sunder-Plassmann
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0218709 (2019)
Trial registrationPEP Study: Ethics committee N° 393/2004, EudraCT 2004-004209-98. PEP-X Study: Ethics committee amendment application N° 154/01/2008. ClinicalTrials.gov NCT03751332.
Externí odkaz:
https://doaj.org/article/089eb0bf36d54eefbeba270869bd904a
Autor:
Max Plischke, Markus Riegersperger, Daniela Dunkler, Georg Heinze, Željko Kikić, Wolfgang C Winkelmayer, Gere Sunder-Plassmann
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135674 (2015)
Tacrolimus (TAC) to ciclosporin A (CSA) conversion studies in stable kidney transplant recipients have reported varying effects on graft function. Here we study graft function (eGFR) trajectories using linear mixed models, which provide effect estima
Externí odkaz:
https://doaj.org/article/16b14ee6e82f46989f29514d53b12b2a
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e113677 (2014)
Statistical models are simple mathematical rules derived from empirical data describing the association between an outcome and several explanatory variables. In a typical modeling situation statistical analysis often involves a large number of potent
Externí odkaz:
https://doaj.org/article/39e2bd43cc6d4543803f81a05917edcb
Autor:
Max Plischke, Maria Kohl, Lise Bankir, Sascha Shayganfar, Ammon Handisurya, Georg Heinze, Martin Haas
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e93226 (2014)
Increasing evidence is linking fluid intake, vasopressin suppression and osmotic control with chronic kidney disease progression. Interestingly, the association between urine volume, urine osmolarity and risk of dialysis initiation has not been studi
Externí odkaz:
https://doaj.org/article/5e95e437ccd8457e8a68595e290bfd09
Publikováno v:
Annals of Nutrition and Metabolism. 66:14-17
Background: Several experimental studies in rats and a few association studies in humans suggest that the antidiuretic action of vasopressin may accelerate the progression of chronic kidney disease. We undertook a retrospective analysis in a monocent
Autor:
Corinna Steinhauser, Gere Sunder-Plassmann, Manuela Födinger, Anita Jallitsch-Halper, Max Plischke, Guerkan Sengoelge, Wolfgang C. Winkelmayer, Markus Riegersperger
Publikováno v:
Clinical laboratory. 62(10)
Background The multidrug resistance 1 gene (ABCB1) encodes P-glycoprotein (PGP), mainly expressed in the liver and engaged in metabolism of drugs including the immunosuppressant tacrolimus (TAC). ABCB1 single nucleotide polymorphisms (SNP) may signif
Autor:
Corinna Steinhauser, Gere Sunder-Plassmann, Markus Riegersperger, Wolfgang C. Winkelmayer, Max Plischke, Anita Jallitsch-Halper, Manuela Födinger, Daniela Dunkler
Publikováno v:
PLoS ONE, Vol 14, Iss 7, p e0218709 (2019)
PLoS ONE
PLoS ONE
In this non-randomized extension study of a randomized controlled trial we converted 87 stable long-term kidney transplant recipients (KTR) from either ciclosporin (CSA, n = 28) or tacrolimus (TAC, n = 59) to TAC modified release (TAC MR4) to study t
Autor:
Christopher Adlbrecht, Guido Strunk, Patrick Vavken, Walter H. Hörl, Bernhard Bielesz, Christian Bieglmayer, Thomas Szekeres, Stephanie Neuhold, Sascha Shayganfar, Max Plischke, Richard Pacher, Martin Hülsmann
Publikováno v:
European Journal of Clinical Investigation. 42:649-656
Eur J Clin Invest 2012; 42 (6): 649–656 Abstract Background Recent studies show associations between inorganic phosphate and risk of heart failure in the general population as well as between fibroblast growth factor 23 (FGF-23) and outcome in coro
Publikováno v:
Wiener klinisches Magazin. 14:6-10
Eine eingeschrankte Nierenfunktion ist bei chronischer Herzinsuffizienz sehrhaufig. Grose Untersuchungen zeigen, dass etwa ein Drittel der symptomatischen Patienten und Patientinnen eine massive Einschrankung aufweisen. Allerdings ist schon eine leic
Publikováno v:
Studies in health technology and informatics. 216
Immunosuppressive therapy is a risky necessity after a patient received a kidney transplant. To reduce risks, a knowledge-based system was developed that determines the right dosage of the immunosuppresive agent Tacrolimus. A theoretical model, to cl